Treatment with agonists of the BDNF/TrkB system of transgenic mouse models of AD increases dendritic spines in the hippocampus and cortex, inhibits neuronal apoptosis and neurodegeneration, and improves spatial memory performance [21,22,23,24,25]. The gene discussed is BDNF; the disease is Alzheimer disease.